Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel. Read more
The $13.4 million PennDOT construction project to realign Langley Avenue is continuing as planned. With the spring season in full swing, the realignment of Langley Avenue has entered into its final stages of reconstruction.
Ameresco, Inc., a leading energy efficiency and renewable energy company, and PIDC, Philadelphia’s public-private economic development corporation and master developer of the Navy Yard, today announced the final completion of the six megawatt (6 MW) natural gas-fired peaking plant at the Navy Yard in Philadelphia, and that the plant is now operational.
In March 2017, Jefferson Health, Liberty Property Trust, and Synterra Partners announced plans for expanded services offered by Jefferson at the Navy Yard, by leasing additional space to open a 70,000-plus square-foot facility at Three Crescent Drive by early to mid-2018. Jefferson’s vision for the Navy Yard is to create a consumer-oriented healthcare destination located in a large, attractive, and highly accessible area for its patients in southeastern Pennsylvania and southern New Jersey. Read more
Liberty Property Trust and PIDC joined WuXi AppTec, Inc., a global leader in pharmaceuticals, biopharmaceuticals, and medical devices, for a ribbon cutting ceremony to open their third facility at the Navy Yard. This new 150,000 square foot facility which, when fully operational, has the potential to accommodate an additional 200 high tech manufacturing and support jobs. Read more
Liberty Property Trust, which owns and manages more than 12 million square feet of office, flex and industrial space in the Greater Philadelphia region, today announced it has pre-leased 26,000 square feet of office space at 1200 Intrepid Avenue to Penn Capital Management Company, Inc. (PENN CAPITAL). This summer the existing Liberty tenant will relocate from Three Crescent Drive in The Navy Yard to its new, larger space, which overlooks a sustainable five-acre park, Central Green. Read more
Adaptimmune Therapeutics plc. (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced plans to locate its U.S. headquarters and clinical operations in a newly developed facility to be constructed at The Navy Yard in Philadelphia. The 47,400 square foot facility, located at 351 Rouse Boulevard in The Navy Yard’s Corporate Center, will house a state-of-the-art cGMP manufacturing facility designed to support the clinical development and initial commercialization of the Company’s novel engineered immunotherapies for cancer. Read more
The year 2014 was another very momentous year for The Navy Yard! We’re taking a look back on some major events and milestones of the year. Read more
As we move into the cooler months, The Navy Yard is still moving full steam ahead with 4 construction and renovation projects! The square footage of these four buildings together represents more than 218,000 square feet of new space at The Navy Yard, as well as over $80 million of investment. Keep reading for details on these projects! Read more
Liberty Property Trust, which owns and manages more than 16 million square feet of office, flex and industrial space in the Greater Philadelphia region, together with its joint venture partner Synterra Partners, broke ground on its third Class A flex building in The Navy Yard Commerce Center (and its fifth flex building at The Navy Yard). The 75,000 square foot building located at 4000 S. 26th Street is 100% pre-leased and will be home to three international tenants when it is completed this December. Read more